Edition:
United States

Aduro Biotech Inc (ADRO.OQ)

ADRO.OQ on NASDAQ Stock Exchange Global Select Market

6.10USD
3:59pm EST
Change (% chg)

$0.00 (+0.00%)
Prev Close
$6.10
Open
$6.20
Day's High
$6.30
Day's Low
$6.05
Volume
63,176
Avg. Vol
114,301
52-wk High
$14.00
52-wk Low
$5.85

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 3.79 -0.326
Jun '17 5.92 -0.273
Mar '17 3.77 -0.320
FY 2016 Dec '16 3.88 -0.439
Sep '16 3.79 -0.538
Jun '16 38.98 0.032
Mar '16 4.03 -0.452
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 4 4.49 6.70 3.70 3.70
Quarter Ending Jun-18 5 4.39 6.70 3.70 3.70
Year Ending Dec-18 7 35.10 74.82 15.02 74.82
Earnings (per share)
Quarter Ending Mar-18 5 -0.36 -0.28 -0.40 --
Quarter Ending Jun-18 5 -0.36 -0.26 -0.41 --
Year Ending Dec-18 7 -1.35 -0.78 -1.66 -1.62
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 187.16 35.64
P/E High - Last 5 Yrs. -- 283.01 46.80
P/E Low - Last 5 Yrs. -- 92.63 24.18
Beta -- 0.81 0.81
Price to Sales (TTM) 27.16 144.25 8.67
Price to Book (MRQ) 1.83 19.79 5.21
Price to Tangible Book (MRQ) 2.17 26.40 6.35
Price to Cash Flow (TTM) -- 124.99 26.03
% Owned Institutions 53.00 11.86 2.27

Dividends

  Company industry sector
Dividend Yield -- 0.28 1.51
Dividend Yield - 5 Year Avg -- 0.20 2.01
Dividend 5 Year Growth Rate -- 1.92 5.24
Payout Ratio(TTM) -- 8.43 44.74

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 0.00 19.88 9.21
Sales (TTM) vs TTM 1 Yr. Ago -78.61 61.01 7.55
Sales - 5 Yr. Growth Rate -- 32.71 10.21
EPS (MRQ) vs Qtr. 1 Yr. Ago 39.38 -97.85 16.86
EPS (TTM) vs TTM 1 Yr. Ago -49.42 -- --
EPS - 5 Yr. Growth Rate -- 46.54 11.51
Capital Spending - 5 Yr. Growth Rate -- 42.29 14.77

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.68 2.42
Current Ratio (MRQ) 10.61 5.73 3.38
LT Debt to Equity (MRQ) 0.00 16.72 12.01
Total Debt to Equity (MRQ) 0.00 18.87 15.38
Interest Coverage (TTM) -- -164.25 39.15

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 51.19 54.84
Gross Margin - 5 Yr. Avg. -- 55.55 52.61
EBITD Margin (TTM) -573.84 -- --
EBITD - 5 Yr. Avg -- -566.09 9.77
Operating Margin (TTM) -596.27 -598.23 2.53
Operating Margin - 5 Yr. Avg. -- -587.15 5.00
Pre-Tax Margin (TTM) -579.55 -568.90 3.34
Pre-Tax Margin - 5 Yr. Avg. -- -595.33 5.26
Net Profit Margin (TTM) -548.92 -564.05 -0.18
Net Profit Margin - 5 Yr. Avg. -- -599.22 1.54
Effective Tax Rate (TTM) -- 0.16 22.12
Effective Tax Rate - 5 Yr. Avg. -- 17.90 24.22

Efficiency

  Company industry sector
Revenue/Employee (TTM) 109,880 23,686,315 822,216,427
Net Income/Employee (TTM) -603,152 -650,139 96,151,835
Receivable Turnover (TTM) 14.44 14.03 5.40
Inventory Turnover (TTM) -- 2.43 3.51
Asset Turnover (TTM) 0.04 0.39 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -20.45 -1.09 10.70
Return on Assets - 5 Yr. Avg. -- -0.33 12.00
Return on Investment (TTM) -22.06 -0.71 13.57
Return on Investment - 5 Yr. Avg. -- 2.30 15.72
Return on Equity (TTM) -37.64 -3.52 15.19
Return on Equity - 5 Yr. Avg. -- -1.79 16.94
  1 Year 3 Year 5 Year
Sales % -30.55 294.10 --
EPS (TTM) % -59.40 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aduro Biotech Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -20.78 -17.20 13 62
13 Week -33.33 -36.21 8 91
26 Week -44.55 -49.93 9 88
52 Week -48.31 -55.25 17 88
YTD -18.67 -19.94 17 91
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 53.01%
# of Holders: 145
Total Shares Held: 40,976,313
3 Mo. Net Change: 1,569,010
# New Positions: 20
# Closed Positions: 15
# Increased Positions: 68
# Reduced Positions: 45
# Net Buyers: 23
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.